Short-term Effects of Good Metabolic Control on Cognitive Function, Wellbeing, and Metabolic Parameters in Adult Patients With Phenylketonuria
NCT04210206 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2023-12-14
Summary
The goal of this study is to evaluate if in adult patients with phenylketonuria (PKU) without strict metabolic control during the last 12 months, strict metabolic control for 8 weeks results in an improvement of cognitive function.
Conditions
- Phenylketonurias
Interventions
- OTHER
-
PHE-diet
phenylalanine-restricted diet with phenylalanine free supplements for 8 weeks
Sponsors & Collaborators
-
Klaus Parhofer
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-01
- Primary Completion
- 2023-08-31
- Completion
- 2023-08-31
Countries
- Germany
Study Locations
More Related Trials
-
Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy
NCT01278966 ·Status: COMPLETED ·Phase: NA
-
Market Research - Acceptability Study for a New PKU Protein Substitute
NCT04318509 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
NCT00552526 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
NCT02261753 ·Status: TERMINATED ·Phase: NA
-
Response to Phenylketonuria to Tetrahydrobiopterin (BH4)
NCT00244218 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria
NCT06901323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Long-term Treatment With the Ketogenic Diet in Epilepsy
NCT04646850 ·Status: ACTIVE_NOT_RECRUITING
-
Metformin in Children With Motor Deficit
NCT00720161 ·Status: COMPLETED ·Phase: NA
-
Ketogenic Diet Program for Epilepsy
NCT02497105 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
NCT02036853 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Ketogenic Dietary Therapy on Sleep in Adult Epilepsy
NCT04193891 ·Status: TERMINATED
-
Short Term Induction of Ketosis in PKD
NCT04472624 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Ketogenic Diet in MELAS Syndrome
NCT06013397 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
NCT07097311 ·Status: RECRUITING ·Phase: PHASE2
-
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
NCT02216500 ·Status: RECRUITING ·Phase: NA
-
The Effects of Breakfast on Neuropsychological Functioning
NCT01943604 ·Status: COMPLETED ·Phase: NA
-
RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy
NCT00564915 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
NCT06554288 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
NCT06637514 ·Status: COMPLETED ·Phase: PHASE2
-
Market Research - Acceptability Study for a Range of MCT Products
NCT04309149 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
NCT02000960 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
NCT02698579 ·Status: ACTIVE_NOT_RECRUITING
-
A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine
NCT06422377 ·Status: TERMINATED ·Phase: PHASE3
-
Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy
NCT01311440 ·Status: COMPLETED ·Phase: NA
-
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
NCT05230758 ·Status: RECRUITING ·Phase: PHASE3